CamGene Therapeutics
Cambridge, GB · 4 known investors
CamGene Therapeutics develops RNA-based medicines, including mRNA, siRNA, and antisense oligonucleotides delivered via lipid nanoparticles, to treat the underlying cellular dysfunction that causes hearing loss. The company aims to modulate protein expression for regeneration and protection of cells in the cochlea as an accessible mass-market therapeutic.
BiotechDeep TechHealthtech
Founders & leadership
AD
Arpan DesaiCEO & Co-founder
PS
Prashant ShahCo-founder
SS
Sunil ShahCo-founder
Investors · 4
Frequently asked questions
- What does CamGene Therapeutics do?
- CamGene Therapeutics develops RNA-based medicines, including mRNA, siRNA, and antisense oligonucleotides delivered via lipid nanoparticles, to treat the underlying cellular dysfunction that causes hearing loss. The company aims to modulate protein expression for regeneration and protection of cells in the cochlea as an accessible mass-market therapeutic.
- Who founded CamGene Therapeutics?
- CamGene Therapeutics was founded by Arpan Desai, Prashant Shah, Sunil Shah.
- Who are CamGene Therapeutics's investors?
- CamGene Therapeutics's investors include Cambridge Angels group, Eos Advisory, Future Planet Capital, UK Innovation & Science Seed Fund.
- Where is CamGene Therapeutics headquartered?
- CamGene Therapeutics is headquartered in Cambridge, GB.